Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

NCT05771857 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 415

Last updated 2023-03-16

No results posted yet for this study

Summary

Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Conditions

Interventions

DEVICE

Obesity

the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19

Sponsors & Collaborators

  • Mohammed VI University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-09-30
Completion
2021-10-01

Countries

  • Morocco

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05771857 on ClinicalTrials.gov